Molecular Therapy-Nucleic Acids

分子疗法-核酸是一种国际性的、开放获取的期刊，在核酸疗法治疗和/或纠正遗传和获得性疾病的广泛领域中，出版高质量的基础、翻译和临床研究。研究领域包括但不限于:基于核酸及其衍生物的治疗方法的开发、基于rna的治疗方法的载体开发和设计、基因修饰剂的应用，包括形成三聚体的寡核苷酸和酶(如锌指核酸酶)、临床前目标验证、安全性/有效性研究和临床试验。分子治疗-核酸2015影响因子为5.048。

Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy — Nucleic Acids 2015 impact factor is 5.048.